Want to see IN:VENUSREM full AI Analyst Report?
Venus Remedies Limited (VENUSREM) Ratios
Venus Remedies Limited Ratios
IN:VENUSREM's free cash flow for Q1 2027 was $0.00. For the 2027 fiscal year, IN:VENUSREM's free cash flow was increased by $0.00 and operating cash flow was $0.00. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.44 | 3.31 | 4.53 | 3.91 | 3.00 |
| Quick Ratio | 1.64 | 2.58 | 2.99 | 2.46 | 1.64 |
| Cash Ratio | 0.19 | 0.59 | 0.62 | 0.26 | 0.47 |
| Solvency Ratio | 0.68 | 0.44 | 0.39 | 0.42 | 0.53 |
| Operating Cash Flow Ratio | 0.97 | 0.67 | 0.47 | 0.44 | 0.44 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 53.80 | 14.09 | 10.13 | 9.84 |
| Net Current Asset Value | $ 2.05B | $ 2.97B | $ 2.20B | $ 1.82B | $ 1.39B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.01 | 0.00 | 0.07 | 0.07 | 0.07 |
| Debt-to-Equity Ratio | 0.02 | 0.00 | 0.08 | 0.09 | 0.10 |
| Debt-to-Capital Ratio | 0.02 | 0.00 | 0.08 | 0.08 | 0.09 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.07 | 0.08 | 0.08 |
| Financial Leverage Ratio | 1.29 | 1.28 | 1.29 | 1.31 | 1.32 |
| Debt Service Coverage Ratio | 3212.50 | 38.58 | 20.08 | 15.80 | 16.02 |
| Interest Coverage Ratio | 3040.25 | 586.14 | 353.87 | 231.52 | 58.41 |
| Debt to Market Cap | 0.00 | 0.00 | 0.09 | 0.19 | 0.12 |
| Interest Debt Per Share | 9.31 | 1.32 | 30.98 | 31.73 | 32.41 |
| Net Debt to EBITDA | -0.11 | -0.83 | -0.11 | 0.30 | -0.01 |
| Profitability Margins | |||||
| Gross Profit Margin | 34.82% | 25.66% | 36.90% | 40.42% | 33.48% |
| EBIT Margin | 17.44% | 11.10% | 7.56% | 6.85% | 6.11% |
| EBITDA Margin | 20.77% | 14.57% | 12.03% | 12.66% | 11.72% |
| Operating Profit Margin | 15.80% | 6.33% | 5.61% | 4.92% | 4.69% |
| Pretax Profit Margin | 17.43% | 11.09% | 7.55% | 6.83% | 6.08% |
| Net Profit Margin | 13.35% | 7.00% | 4.82% | 4.78% | 6.80% |
| Continuous Operations Profit Margin | 13.36% | 7.00% | 4.82% | 4.78% | 6.80% |
| Net Income Per EBT | 76.61% | 63.09% | 63.82% | 70.05% | 111.85% |
| EBT Per EBIT | 110.32% | 175.07% | 134.64% | 138.84% | 129.58% |
| Return on Assets (ROA) | 12.04% | 6.33% | 4.55% | 4.42% | 7.02% |
| Return on Equity (ROE) | 15.48% | 8.08% | 5.84% | 5.77% | 9.25% |
| Return on Capital Employed (ROCE) | 17.58% | 7.08% | 6.06% | 5.27% | 5.77% |
| Return on Invested Capital (ROIC) | 13.44% | 4.45% | 3.85% | 3.67% | 5.72% |
| Return on Tangible Assets | 13.53% | 7.42% | 5.26% | 5.09% | 8.28% |
| Earnings Yield | 9.38% | 10.72% | 6.30% | 12.24% | 11.27% |
| Efficiency Ratios | |||||
| Receivables Turnover | 6.90 | 5.77 | 7.24 | 7.14 | 13.78 |
| Payables Turnover | 4.42 | 5.24 | 8.45 | 6.51 | 7.94 |
| Inventory Turnover | 3.88 | 4.79 | 3.07 | 2.76 | 3.17 |
| Fixed Asset Turnover | 4.07 | 4.29 | 3.81 | 3.41 | 3.35 |
| Asset Turnover | 0.90 | 0.91 | 0.94 | 0.92 | 1.03 |
| Working Capital Turnover Ratio | 2.80 | 2.18 | 2.27 | 2.61 | 3.72 |
| Cash Conversion Cycle | 64.42 | 69.76 | 126.27 | 127.33 | 95.66 |
| Days of Sales Outstanding | 52.86 | 63.22 | 50.42 | 51.12 | 26.48 |
| Days of Inventory Outstanding | 94.14 | 76.16 | 119.02 | 132.26 | 115.16 |
| Days of Payables Outstanding | 82.58 | 69.62 | 43.17 | 56.06 | 45.98 |
| Operating Cycle | 147.00 | 139.38 | 169.45 | 183.39 | 141.64 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 117.69 | 68.00 | 27.89 | 27.40 | 30.67 |
| Free Cash Flow Per Share | 89.49 | 60.80 | 20.82 | 21.55 | 20.42 |
| Dividend Paid and CapEx Coverage Ratio | 4.17 | 9.44 | 4.00 | 4.68 | 2.99 |
| Capital Expenditure Coverage Ratio | 4.17 | 9.44 | 4.00 | 4.68 | 2.99 |
| Operating Cash Flow Coverage Ratio | 12.68 | 53.80 | 0.90 | 0.87 | 0.96 |
| Operating Cash Flow to Sales Ratio | 0.20 | 0.14 | 0.06 | 0.07 | 0.07 |
| Free Cash Flow Yield | 10.91% | 19.23% | 6.15% | 13.26% | 7.55% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 10.67 | 9.33 | 15.88 | 8.17 | 8.87 |
| Price-to-Sales (P/S) Ratio | 1.42 | 0.65 | 0.76 | 0.39 | 0.60 |
| Price-to-Book (P/B) Ratio | 1.65 | 0.75 | 0.93 | 0.47 | 0.82 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 9.16 | 5.20 | 16.25 | 7.54 | 13.24 |
| Price-to-Operating Cash Flow Ratio | 6.97 | 4.65 | 12.13 | 5.93 | 8.81 |
| Price-to-Earnings Growth (PEG) Ratio | 0.08 | 0.16 | 2.19 | -0.23 | -0.23 |
| Enterprise Value Multiple | 6.74 | 3.65 | 6.25 | 3.39 | 5.15 |
| Enterprise Value | 10.78B | 3.44B | 4.45B | 2.38B | 3.61B |
| EV to EBITDA | 6.74 | 3.65 | 6.25 | 3.39 | 5.15 |
| EV to Sales | 1.40 | 0.53 | 0.75 | 0.43 | 0.60 |
| EV to Free Cash Flow | 9.01 | 4.24 | 15.97 | 8.27 | 13.22 |
| EV to Operating Cash Flow | 6.85 | 3.79 | 11.93 | 6.51 | 8.80 |
| Tangible Book Value Per Share | 426.24 | 341.24 | 300.93 | 285.11 | 263.72 |
| Shareholders’ Equity Per Share | 496.56 | 419.57 | 364.67 | 344.39 | 329.50 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.23 | 0.37 | 0.36 | 0.30 | -0.12 |
| Revenue Per Share | 575.75 | 484.60 | 442.38 | 415.58 | 447.86 |
| Net Income Per Share | 76.89 | 33.90 | 21.31 | 19.88 | 30.47 |
| Tax Burden | 0.77 | 0.63 | 0.64 | 0.70 | 1.12 |
| Interest Burden | 1.00 | 1.00 | 1.00 | 1.00 | 0.99 |
| Research & Development to Revenue | 0.02 | 0.03 | 0.03 | 0.04 | 0.04 |
| SG&A to Revenue | 0.17 | 0.29 | 0.02 | 0.02 | 0.02 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.53 | 2.01 | 1.31 | 0.97 | 1.13 |
Currency in INR
